Table 1.
No | RT | VIP | Formula | Metabolites | SM | m/z | Fold Change | |
---|---|---|---|---|---|---|---|---|
PQ/C | AEE/PQ | |||||||
1 | 1.036 | 1.08 | C6H9N3O2 | L-Histidine | ESI+ | 155.1546 | 0.86 | 1.03 |
2 | 1.146 | 2.51 | C6H11NO2 | Pipecolic acid | ESI+ | 129.157 | 0.78 | 1.16* |
3 | 1.154 | 1.06 | C8H20NO6P | Glycerophosphocholine | ESI+ | 257.223 | 1.34 | 0.74* |
4 | 1.213 | 3.14 | C4H7NO3 | Acetylglycine | ESI+ | 117.1033 | 0.77 | 1.63* |
5 | 1.314 | 1.05 | C6H13NO | N-(2-Methylpropyl)acetamide | ESI+ | 115.1735 | 1.04 | 1.47* |
6 | 1.817 | 2.46 | C4H8N2O3 | D-Asparagine | ESI+ | 132.1179 | 0.92 | 1.55* |
7 | 3.638 | 1.17 | C5H4N4O | Hypoxanthine | ESI+ | 136.1115 | 1.37 | 0.92* |
8 | 3.646 | 1.09 | C10H12N4O5 | Inosine | ESI+ | 268.2261 | 0.85 | 1.15* |
9 | 4.517 | 2.84 | C10H12N4O6 | Xanthosine | ESI+ | 284.2255 | 0.98 | 1.85* |
10 | 4.627 | 4.61 | C9H11NO2 | L-Phenylalanine | ESI+ | 165.1891 | 0.46 | 1.48* |
11 | 4.779 | 2.43 | C13H17N2O3 | Melatonin radical | ESI+ | 249.2857 | 0.39 | 0.75* |
12 | 4.959 | 1.73 | C11H19N3O6 | Ophthalmic acid | ESI+ | 289.2851 | 0.40 | 0.85* |
13 | 5.379 | 1.24 | C14H28O2 | Nonyl isovalerate | ESI+ | 228.3709 | 0.91 | 0.80 |
14 | 5.717 | 1.42 | C11H21N5O5 | Glutamylarginine | ESI+ | 303.319 | 0.49 | 0.98* |
15 | 5.802 | 1.26 | C11H20N2O5 | Glutamylleucine | ESI+ | 260.29 | 0.91 | 0.64 |
16 | 6.368 | 1.57 | C6H11NO2 | Pipecolic acid | ESI+ | 129.157 | 1.47 | 1.04* |
17 | 6.682 | 1.07 | C30H47N3O10S | S-(PGJ2)-glutathione | ESI+ | 641.773 | 0.65 | 1.19* |
18 | 9.368 | 1.04 | C15H29NO4 | L-Octanoylcarnitine | ESI+ | 287.3951 | 0.60 | 2.18* |
19 | 9.419 | 1.46 | C24H50NO6P | LysoPC(P-16:0) | ESI+ | 479.6307 | 1.80 | 3.18* |
20 | 10.117 | 1.06 | C6H13N3O3 | Argininic acid | ESI+ | 175.1857 | 0.79 | 1.78* |
21 | 13.354 | 2.48 | C26H43NO5 | Deoxycholic acid glycine conjugate | ESI+ | 449.6233 | 0.85 | 0.82 |
22 | 13.969 | 2.42 | C13H25NO3 | N-Undecanoylglycine | ESI+ | 243.3425 | 0.89 | 1.07 |
23 | 4.995 | 3.96 | C21H35N7O13P2S | Dephospho-CoA | ESI- | 687.15 | 1.95 | 1.04* |
24 | 9.331 | 5.39 | C26H45NO6S | Taurochenodesoxycholic acid | ESI- | 499.3 | 1.44 | 0.89* |
25 | 10.677 | 1.07 | C22H44NO7P | LysoPC(14:1) | ESI- | 465.561 | 2.15 | 1.04* |
26 | 10.776 | 3.14 | C26H43NO5 | Chenodeoxyglycocholic acid | ESI- | 449.6233 | 1.97 | 2.33 |
27 | 11.221 | 2.03 | C47H89O8P | PA(22:2) | ESI- | 813.195 | 1.29 | 1.11 |
28 | 12.143 | 2.50 | C24H40O5 | Cholic acid | ESI- | 408.5714 | 2.05 | 0.82* |
29 | 14.502 | 1.11 | C30H37NO8 | 5,9,11-trihydroxyprosta-6E,14Z-dien-1-oate | ESI- | 539.625 | 1.29 | 0.77* |
30 | 14.897 | 1.61 | C23H44NO7P | LysoPE(18:2) | ESI- | 477.5717 | 1.33 | 0.92* |
31 | 14.973 | 1.15 | C25H44NO7P | LysoPE(20:4) | ESI- | 501.5931 | 2.06 | 0.75* |
32 | 15.650 | 1.69 | C21H44NO7P | LysoPE(16:0) | ESI- | 453.5503 | 1.65 | 1.01* |
RT, retention time; VIP, variable importance in the projection; SM, scan mode; +, metabolites identified in positive mode; –, metabolites identified in negative mode. Metabolites identified in both positive and negative modes;
p < 0.05 compared with the PQ group; C/PQ, control group compared with the PQ group; AEE/PQ, AEE group compared with the PQ group.